AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. IVVD
  4. [Form 4] Invivyd, Inc. Insider Trading Activity

[Form 4] Invivyd, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Jill Andersen, Chief Legal Officer and Secretary of Invivyd, Inc. (IVVD), reported equity activity on Form 4 related to restricted stock units and subsequent sell-to-cover sales. On 08/15/2025 she was credited with 165,000 RSUs (each converting to one common share) under an award that vests one-third every six months beginning from a 02/15/2025 grant date. Following vesting, she sold 33,352 shares on 08/18/2025 at a weighted average price of $0.6502 and 49,402 shares on 08/19/2025 at a weighted average price of $0.5666, in non-discretionary sell-to-cover transactions adopted under a Rule 10b5-1 plan. The Form shows 84,446 shares beneficially owned after the reported sales (direct), plus 500 shares indirectly held by spouse.

Jill Andersen, Chief Legal Officer e Corporate Secretary di Invivyd, Inc. (IVVD), ha dichiarato attivit脿 azionarie nel Modulo 4 (Form 4) riguardanti unit脿 azionarie vincolate (RSU) e successive vendite "sell-to-cover". Il 15/08/2025 le sono state accreditate 165.000 RSU (ciascuna convertibile in una azione ordinaria) nell'ambito di un premio che matura per un terzo ogni sei mesi a partire dalla data di attribuzione del 15/02/2025. Dopo il vesting, ha venduto in operazioni non discrezionali di sell-to-cover previste da un piano ai sensi della Rule 10b5-1 33.352 azioni il 18/08/2025 al prezzo medio ponderato di $0,6502 e 49.402 azioni il 19/08/2025 al prezzo medio ponderato di $0,5666. Il Form indica inoltre 84.446 azioni possedute direttamente dopo le vendite dichiarate, oltre a 500 azioni detenute indirettamente dal coniuge.

Jill Andersen, Chief Legal Officer y Secretaria de Invivyd, Inc. (IVVD), report贸 actividad accionaria en el Formulario 4 (Form 4) relacionada con unidades restringidas de acciones (RSU) y posteriores ventas "sell-to-cover". El 15/08/2025 se le acreditaron 165.000 RSU (cada una convertible en una acci贸n ordinaria) bajo una adjudicaci贸n que devenga un tercio cada seis meses desde la fecha de concesi贸n del 15/02/2025. Tras el vesting, vendi贸 en transacciones no discrecionales sell-to-cover establecidas bajo un plan Rule 10b5-1 33.352 acciones el 18/08/2025 a un precio medio ponderado de $0.6502 y 49.402 acciones el 19/08/2025 a un precio medio ponderado de $0.5666. El formulario muestra adem谩s 84.446 acciones pose铆das beneficiosamente despu茅s de las ventas reportadas (directas), m谩s 500 acciones mantenidas indirectamente por su c贸nyuge.

Jill Andersen, Invivyd, Inc. (IVVD)鞚� 斓滉碃氩曤毂呾瀯鞛�(Chief Legal Officer) 瓴� 靹滉赴(Secretary)電� 鞝滍暅攵� 欤检嫕 雼渼(RSU) 氚� 鞚错泟鞚� 靺�韴护氩�(sell-to-cover) 毵り皝瓿� 甏�霠暅 欤检嫕 瓯半灅毳� Form 4鞐� 氤搓碃頄堨姷雼堧嫟. 2025雲� 8鞗� 15鞚检棎 165,000 RSU臧� 攵�鞐悩鞐堨溂氅�(臧� RSU電� 氤错喌欤� 1欤茧 鞝勴櫂), 鞚措姅 2025雲� 2鞗� 15鞚� 攵�鞐澕搿滊秬韯� 6臧滌洈毵堧嫟 1/3鞌� 氩犾姢韺呺惄雼堧嫟. 氩犾姢韺� 鞚错泟, Rule 10b5-1 瓿勴殟鞐� 霐半澕 牍勳灛霟夓爜(non-discretionary) 靺�韴护氩� 瓯半灅搿� 2025-08-18鞐� 33,352欤�毳� 臧�欷� 韽夑窢臧�瓴� $0.6502鞐�, 2025-08-19鞐� 49,402欤�毳� 臧�欷� 韽夑窢臧�瓴� $0.5666鞐� 毵り皝頄堨姷雼堧嫟. 氤搓碃霅� 毵り皝 頉� Form鞐愲姅 歆侅爲 氤挫湢 旮办鞙茧 84,446欤�臧� 鞛堨溂氅�, 氚办毎鞛愱皜 臧勳爲鞝侅溂搿� 氤挫湢頃� 500欤�霃� 響滉赴霅橃柎 鞛堨姷雼堧嫟.

Jill Andersen, Chief Legal Officer et Secr茅taire d'Invivyd, Inc. (IVVD), a d茅clar茅 des op茅rations sur titres dans le Formulaire 4 (Form 4) relatives 脿 des restricted stock units (RSU) et 脿 des ventes ult茅rieures "sell-to-cover". Le 15/08/2025, elle s'est vu attribuer 165 000 RSU (chacune convertible en une action ordinaire) dans le cadre d'une attribution qui acquiert un tiers tous les six mois 脿 compter de la date d'octroi du 15/02/2025. Apr猫s le vesting, elle a vendu lors de transactions non discr茅tionnaires de sell-to-cover mises en place dans le cadre d'un plan Rule 10b5-1 33 352 actions le 18/08/2025 au prix moyen pond茅r茅 de $0,6502 et 49 402 actions le 19/08/2025 au prix moyen pond茅r茅 de $0,5666. Le formulaire indique 茅galement 84 446 actions d茅tenues de mani猫re b茅n茅ficiaire apr猫s les ventes d茅clar茅es (directement), plus 500 actions d茅tenues indirectement par son conjoint.

Jill Andersen, Chief Legal Officer und Secretary von Invivyd, Inc. (IVVD), meldete im Form 4 Aktientransaktionen im Zusammenhang mit Restricted Stock Units (RSU) und anschlie脽enden Sell-to-Cover-Verk盲ufen. Am 15.08.2025 wurden ihr 165.000 RSUs gutgeschrieben (jeweils in eine Stammaktie wandelbar) im Rahmen einer Zuteilung, die zu einem Drittel alle sechs Monate ab dem Zuteilungsdatum 15.02.2025 vestet. Nach dem Vesting verkaufte sie in nicht-diskretion盲ren Sell-to-Cover-Transaktionen, die unter einem Rule 10b5-1-Plan durchgef眉hrt wurden, 33.352 Aktien am 18.08.2025 zum gewichteten Durchschnittspreis von $0,6502 und 49.402 Aktien am 19.08.2025 zum gewichteten Durchschnittspreis von $0,5666. Das Formular weist ferner 84.446 Aktien als nach den berichteten Verk盲ufen vorteilhaft gehalten (direkt) aus, zuz眉glich 500 Aktien, die indirekt vom Ehepartner gehalten werden.

Positive
  • Sales were executed under a Rule 10b5-1 plan, indicating pre-established, non-discretionary execution and governance controls
  • Disclosed weighted-average prices and price ranges with offer to provide per-trade details demonstrates transparent reporting
  • RSU vesting schedule is clearly stated (one-third every six months from 02/15/2025), clarifying future potential issuance timing
Negative
  • None.

Insights

TL;DR: Insider sold shares to cover RSU taxes under a 10b5-1 plan; transactions appear routine and non-material to company valuation.

The filings show an award of 165,000 RSUs that vest over 18 months and scheduled sell-to-cover disposals executed via a Rule 10b5-1 plan on 08/18 and 08/19/2025. The disclosed weighted-average sale prices were $0.6502 and $0.5666. The transactions reduced the reporting person鈥檚 direct holdings to 84,446 shares; 500 shares are reported indirectly by spouse. From a capital structure perspective, these are executive compensation-related conversions and tax-withholding sales rather than open-market liquidation of long-held stakes, implying limited signal on management conviction.

TL;DR: Use of a pre-established Rule 10b5-1 plan and detailed footnotes indicates procedural compliance and transparent reporting.

The Form 4 discloses that the sales were executed pursuant to a 10b5-1 plan adopted 02/20/2025 and specifies price ranges and willingness to provide per-trade detail to the SEC or company. The RSU vesting schedule is stated clearly (one-third every six months). These disclosures reflect good practice for insider trading governance and accurate Section 16 reporting.

Jill Andersen, Chief Legal Officer e Corporate Secretary di Invivyd, Inc. (IVVD), ha dichiarato attivit脿 azionarie nel Modulo 4 (Form 4) riguardanti unit脿 azionarie vincolate (RSU) e successive vendite "sell-to-cover". Il 15/08/2025 le sono state accreditate 165.000 RSU (ciascuna convertibile in una azione ordinaria) nell'ambito di un premio che matura per un terzo ogni sei mesi a partire dalla data di attribuzione del 15/02/2025. Dopo il vesting, ha venduto in operazioni non discrezionali di sell-to-cover previste da un piano ai sensi della Rule 10b5-1 33.352 azioni il 18/08/2025 al prezzo medio ponderato di $0,6502 e 49.402 azioni il 19/08/2025 al prezzo medio ponderato di $0,5666. Il Form indica inoltre 84.446 azioni possedute direttamente dopo le vendite dichiarate, oltre a 500 azioni detenute indirettamente dal coniuge.

Jill Andersen, Chief Legal Officer y Secretaria de Invivyd, Inc. (IVVD), report贸 actividad accionaria en el Formulario 4 (Form 4) relacionada con unidades restringidas de acciones (RSU) y posteriores ventas "sell-to-cover". El 15/08/2025 se le acreditaron 165.000 RSU (cada una convertible en una acci贸n ordinaria) bajo una adjudicaci贸n que devenga un tercio cada seis meses desde la fecha de concesi贸n del 15/02/2025. Tras el vesting, vendi贸 en transacciones no discrecionales sell-to-cover establecidas bajo un plan Rule 10b5-1 33.352 acciones el 18/08/2025 a un precio medio ponderado de $0.6502 y 49.402 acciones el 19/08/2025 a un precio medio ponderado de $0.5666. El formulario muestra adem谩s 84.446 acciones pose铆das beneficiosamente despu茅s de las ventas reportadas (directas), m谩s 500 acciones mantenidas indirectamente por su c贸nyuge.

Jill Andersen, Invivyd, Inc. (IVVD)鞚� 斓滉碃氩曤毂呾瀯鞛�(Chief Legal Officer) 瓴� 靹滉赴(Secretary)電� 鞝滍暅攵� 欤检嫕 雼渼(RSU) 氚� 鞚错泟鞚� 靺�韴护氩�(sell-to-cover) 毵り皝瓿� 甏�霠暅 欤检嫕 瓯半灅毳� Form 4鞐� 氤搓碃頄堨姷雼堧嫟. 2025雲� 8鞗� 15鞚检棎 165,000 RSU臧� 攵�鞐悩鞐堨溂氅�(臧� RSU電� 氤错喌欤� 1欤茧 鞝勴櫂), 鞚措姅 2025雲� 2鞗� 15鞚� 攵�鞐澕搿滊秬韯� 6臧滌洈毵堧嫟 1/3鞌� 氩犾姢韺呺惄雼堧嫟. 氩犾姢韺� 鞚错泟, Rule 10b5-1 瓿勴殟鞐� 霐半澕 牍勳灛霟夓爜(non-discretionary) 靺�韴护氩� 瓯半灅搿� 2025-08-18鞐� 33,352欤�毳� 臧�欷� 韽夑窢臧�瓴� $0.6502鞐�, 2025-08-19鞐� 49,402欤�毳� 臧�欷� 韽夑窢臧�瓴� $0.5666鞐� 毵り皝頄堨姷雼堧嫟. 氤搓碃霅� 毵り皝 頉� Form鞐愲姅 歆侅爲 氤挫湢 旮办鞙茧 84,446欤�臧� 鞛堨溂氅�, 氚办毎鞛愱皜 臧勳爲鞝侅溂搿� 氤挫湢頃� 500欤�霃� 響滉赴霅橃柎 鞛堨姷雼堧嫟.

Jill Andersen, Chief Legal Officer et Secr茅taire d'Invivyd, Inc. (IVVD), a d茅clar茅 des op茅rations sur titres dans le Formulaire 4 (Form 4) relatives 脿 des restricted stock units (RSU) et 脿 des ventes ult茅rieures "sell-to-cover". Le 15/08/2025, elle s'est vu attribuer 165 000 RSU (chacune convertible en une action ordinaire) dans le cadre d'une attribution qui acquiert un tiers tous les six mois 脿 compter de la date d'octroi du 15/02/2025. Apr猫s le vesting, elle a vendu lors de transactions non discr茅tionnaires de sell-to-cover mises en place dans le cadre d'un plan Rule 10b5-1 33 352 actions le 18/08/2025 au prix moyen pond茅r茅 de $0,6502 et 49 402 actions le 19/08/2025 au prix moyen pond茅r茅 de $0,5666. Le formulaire indique 茅galement 84 446 actions d茅tenues de mani猫re b茅n茅ficiaire apr猫s les ventes d茅clar茅es (directement), plus 500 actions d茅tenues indirectement par son conjoint.

Jill Andersen, Chief Legal Officer und Secretary von Invivyd, Inc. (IVVD), meldete im Form 4 Aktientransaktionen im Zusammenhang mit Restricted Stock Units (RSU) und anschlie脽enden Sell-to-Cover-Verk盲ufen. Am 15.08.2025 wurden ihr 165.000 RSUs gutgeschrieben (jeweils in eine Stammaktie wandelbar) im Rahmen einer Zuteilung, die zu einem Drittel alle sechs Monate ab dem Zuteilungsdatum 15.02.2025 vestet. Nach dem Vesting verkaufte sie in nicht-diskretion盲ren Sell-to-Cover-Transaktionen, die unter einem Rule 10b5-1-Plan durchgef眉hrt wurden, 33.352 Aktien am 18.08.2025 zum gewichteten Durchschnittspreis von $0,6502 und 49.402 Aktien am 19.08.2025 zum gewichteten Durchschnittspreis von $0,5666. Das Formular weist ferner 84.446 Aktien als nach den berichteten Verk盲ufen vorteilhaft gehalten (direkt) aus, zuz眉glich 500 Aktien, die indirekt vom Ehepartner gehalten werden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Andersen Jill
(Last) (First) (Middle)
C/O INVIVYD, INC.
1601 TRAPELO ROAD, SUITE 178
(Street)
WALTHAM MA 02451
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Invivyd, Inc. [ IVVD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer, Secretary
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2025 M 165,000 A (1) 167,200 D
Common Stock 08/18/2025 S 33,352(2) D $0.6502(3) 133,848 D
Common Stock 08/19/2025 S 49,402(2) D $0.5666(4) 84,446 D
Common Stock 500 I By spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 08/15/2025 M 165,000 (5) (5) Common Stock 165,000 $0.00 335,000 D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
2. The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5801 to $0.7134, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5524 to $0.6040, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
5. This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
Remarks:
Exhibit 24.1: Power of Attorney
/s/ Jill Andersen 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What did Invivyd (IVVD) insider Jill Andersen report on Form 4?

The report discloses receipt of 165,000 RSUs on 08/15/2025 and sell-to-cover sales of 33,352 shares on 08/18/2025 at a weighted average of $0.6502 and 49,402 shares on 08/19/2025 at $0.5666.

Why were shares sold by the reporting person?

The sales were non-discretionary sell-to-cover transactions to satisfy tax withholding obligations upon RSU vesting, executed under a Rule 10b5-1 plan.

How many shares does Jill Andersen beneficially own after these transactions?

After the reported transactions the Form shows 84,446 shares held directly and 500 shares indirectly by her spouse.

When do the RSUs vest and how many were granted?

The RSU award of 165,000 units vests over an 18-month period with one-third vesting every six months, based on the 02/15/2025 grant date.

Was the 10b5-1 plan adoption date disclosed?

Yes. The Form states the Reporting Person adopted the Rule 10b5-1 plan on 02/20/2025.
Stock IVVD logo
Invivyd

NASDAQ:IVVD

IVVD Rankings

#5006 Ranked by Market Cap
N/A Ranked by Dividends
#1 Top Loser

IVVD Latest News

Aug 20, 2025
Invivyd Announces Pricing of $50 Million Public Offering of Common Stock and Pre-Funded Warrants
Aug 20, 2025
Invivyd Announces Proposed Public Offering of Common Stock
Aug 18, 2025
Invivyd Announces Continued Neutralizing Activity of PEMGARDA庐 (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (鈥淪tratus鈥�)
Aug 14, 2025
Invivyd Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Aug 14, 2025
Invivyd Aligns with U.S. FDA on Rapid Pathway to Full Approval (BLA) of Vaccine Alternative Monoclonal Antibody VYD2311 to Protect American Adults and Adolescents from COVID-19

IVVD Latest SEC Filings

Aug 20, 2025
[424B5] Invivyd, Inc. Prospectus Supplement (Debt Securities)
Aug 19, 2025
[Form 4] Invivyd, Inc. Insider Trading Activity
Aug 19, 2025
[Form 4] Invivyd, Inc. Insider Trading Activity
Aug 19, 2025
[Form 4] Invivyd, Inc. Insider Trading Activity
Aug 19, 2025
[Form 4] Invivyd, Inc. Insider Trading Activity

IVVD Stock Data

69.71M
69.63M
41.12%
57.5%
2.77%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
WALTHAM